Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 14, 2025
Event Date: May 9, 2025 (Execution of Amendment)
The Company entered into a First Amendment to a Membership Interest Purchase Agreement originally dated May 1, 2023, regarding the acquisition of Medtech Concepts, LLC.
Key Financial Metrics
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, or margins. The primary financial impact relates to the restructuring of acquisition consideration.
- Amended Consideration Value: Approximately $3,750,000.
- Payment Structure: Three installments of $1,250,000 each.
- Payment Dates: On or about May 1, 2025; May 1, 2026; and May 1, 2027.
- Instrument: Unregistered shares of Common Stock (par value $0.00025) issued in lieu of cash.
Material Changes Versus Prior Period
The material change involves the conversion of remaining cash obligations into equity:
- Prior Obligation: Three remaining annual cash payments of $1,250,000 each were required under the original Purchase Agreement.
- New Obligation: These cash payments are replaced by the issuance of unregistered Common Stock representing an aggregate value of $3,750,000, payable in three equal tranches over three years.
Guidance, Outlook, and Risks
Management Commentary: The filing details the amendment to the acquisition agreement but does not provide forward-looking guidance, outlook, or general management commentary on operations.
Risks and Contingencies:
- Equity Dilution: The issuance of unregistered shares may result in dilution to existing shareholders.
- Regulatory Exemption: The issuance relies on an exemption under Section 4(a)(2) of the Securities Act of 1933.
Unusual Items: None reported beyond the amendment of the acquisition payment terms.
Investor Verification Checklist
- Verify the exact number of shares to be issued for each $1,250,000 installment based on the share price at the time of issuance.
- Review the full text of the First Amendment (Exhibit 2.1) for any covenants or conditions attached to the stock issuance.
- Assess the impact of the equity issuance on the Company's capitalization table and potential dilution.
- Confirm the status of the original May 1, 2023, Purchase Agreement to ensure no other outstanding cash obligations remain.